Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
Circulating Tumor DNA Exposure in Peripheral Blood
Get alerts for new trials in your area by subscribing now
Registry Study for Radiation Therapy Outcomes
for
Neoplasms
Location: Orlando FL, Jacksonville FL, Fort Myers FL,
Sponsor: Proton Collaborative Group
Sex: All
Age: 0+
Code: NCT01255748
Recruiting
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for
Unresectable Melanoma, Metastatic Melanoma,
Location: Orlando FL, Tampa FL, Miami FL, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05361174
Phase 1, Phase 2, Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Orlando FL, Tampa FL, Fort Myers FL, Newnan GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07365241
Phase 3, Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Orlando FL, Tampa FL, Miami FL, Washington D.C. DC,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05208047
Phase 3, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Orlando FL, Hollywood FL, Augusta GA, Columbia SC,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
for
Small Cell Lung Cancer
Location: Orlando FL, Grand Rapids MI, Omaha NE
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07778316
Phase 3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Orlando FL, Ocoee FL, Wesley Chapel FL, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase 3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Orlando FL, Jacksonville FL, St. Petersburg FL,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Orlando FL, Tampa FL, Fairhope AL, Clinton NC,